Mike Polark
Stock Analyst at Baird
(3.31)
# 1,014
Out of 4,711 analysts
75
Total ratings
51.16%
Success rate
2.97%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVRO Nevro | Maintains: Neutral | $5 → $6 | $3.79 | +58.31% | 10 | Nov 12, 2024 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $240 → $252 | $187.77 | +34.21% | 5 | Nov 5, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $100 → $79 | $90.39 | -12.60% | 7 | Nov 1, 2024 | |
| RMD ResMed | Downgrades: Underperform | $180 | $237.27 | -24.14% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $107.12 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $364.60 | +11.08% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $47.59 | +15.57% | 8 | Aug 28, 2024 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $74.81 | - | 3 | Jul 29, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $524.43 | -4.09% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $266.57 | -24.97% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $114.23 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $178.16 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $80.04 | +51.17% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $35.91 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $13.24 | +88.82% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $169.52 | -2.67% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $88.95 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $81.03 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $11.53 | +12.75% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $8.01 | +162.17% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $207.49 | +20.49% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.43 | +1,669.55% | 1 | Sep 2, 2020 |
Nevro
Nov 12, 2024
Maintains: Neutral
Price Target: $5 → $6
Current: $3.79
Upside: +58.31%
Inspire Medical Systems
Nov 5, 2024
Maintains: Outperform
Price Target: $240 → $252
Current: $187.77
Upside: +34.21%
iRhythm Technologies
Nov 1, 2024
Maintains: Outperform
Price Target: $100 → $79
Current: $90.39
Upside: -12.60%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $237.27
Upside: -24.14%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $107.12
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $364.60
Upside: +11.08%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $47.59
Upside: +15.57%
Edwards Lifesciences
Jul 29, 2024
Upgrades: Peer Perform
Price Target: n/a
Current: $74.81
Upside: -
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $524.43
Upside: -4.09%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $266.57
Upside: -24.97%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $114.23
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $178.16
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $80.04
Upside: +51.17%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $35.91
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $13.24
Upside: +88.82%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $169.52
Upside: -2.67%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $88.95
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $81.03
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $11.53
Upside: +12.75%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $8.01
Upside: +162.17%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $207.49
Upside: +20.49%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.43
Upside: +1,669.55%